Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating Activities:
Net income	$ 22,256	$ 28,646
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	38,531	30,470
Deferred income taxes	(3,017)	(1,207)
Stock based compensation	8,451	3,383
Loss on disposition of property and equipment	873	620
Provisions for inventory	6,597	4,293
Impairment of goodwill	19,509
Other	81	881
Changes in assets and liabilities:
Accounts receivable, net	(19,813)	(55,780)
Inventory	3,733	(53,223)
Other assets	(19,218)	(10,868)
Accounts payable	32,158	60,983
Other liabilities	(10,099)	4,759
Net cash provided by operating activities	80,042	12,957
Investing Activities:
Purchases of property and equipment	(26,526)	(25,737)
Proceeds from the sale of property and equipment	72	175
Acquisition of businesses, net of cash acquired		(224,097)
Proceeds from deferred purchase price of factored receivables	10,139	2,168
Cost of technology investments	(630)	(350)
Net cash used in investing activities	(16,945)	(247,841)
Financing Activities:
Borrowings on debt		207,000
Repayments of debt	(27,166)	(11,559)
Proceeds from the exercise of Common Stock options	263	1,556
Taxes withheld and paid on employees' share-based payment awards	(2,754)	(5,415)
Cash paid for the repurchase of Common Stock	(31,094)
Net cash (used in) provided by financing activities	(60,751)	191,582
Foreign currency effect	(1,883)	(8,141)
Net cash increase (decrease) in cash and cash equivalents	463	(51,443)
Cash and cash equivalents at beginning of period	153,891	190,606
Cash and cash equivalents at end of period	154,354	139,163
Supplemental disclosure of cash flow information:
Cash paid for taxes	18,893	13,509
Cash paid for interest	9,737	3,334
Non-Cash Investing Activities:
Period-end balance of accounts payable for property and equipment	4,501	2,848
Deferred purchase price of receivables factored in the period	$ 11,344	$ 2,801